• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. Oct 1991; 35(10): 2140–2143.
PMCID: PMC245342

In vitro activity of 79 antimicrobial agents against Corynebacterium group D2.


Corynebacterium group D2 (CGD2) is involved in urinary tract infections in patients with underlying predisposing factors. This microorganism is highly resistant to a number of antimicrobial agents. We tested the activities of 79 antimicrobial agents against CGD2. beta-Lactams, aminoglycosides, and macrolides were ineffective. Fluorinated quinolones showed irregular activities, ofloxacin being the most active one. Doxycycline, rifampin, and mainly glycopeptides (vancomycin and teicoplanin) were the most active antibiotics against CGD2.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (525K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aguado JM, Ponte C, Soriano F. Bacteriuria with a multiply resistant species of Corynebacterium (Corynebacterium group D2): an unnoticed cause of urinary tract infection. J Infect Dis. 1987 Jul;156(1):144–150. [PubMed]
  • Fernández-Roblas R, Prieto S, Santamaría M, Ponte C, Soriano F. Activity of nine antimicrobial agents against Corynebacterium group D2 strains isolated from clinical specimens and skin. Antimicrob Agents Chemother. 1987 May;31(5):821–822. [PMC free article] [PubMed]
  • Johnson WD, Kaye D. Serious infections caused by diphtheroids. Ann N Y Acad Sci. 1970 Oct 30;174(2):568–576. [PubMed]
  • Marty N, Clave D, Cancet B, Henry-Ferry S, Didier J. Corynebacterium groupe D2. Etude clinique, identification biochimique et sensibilité aux antibiotiques. Pathol Biol (Paris) 1988 May;36(5):460–464. [PubMed]
  • Philippon A, Bimet F. In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics. Eur J Clin Microbiol Infect Dis. 1990 Dec;9(12):892–895. [PubMed]
  • Santamaría M, Ponte C, Wilhelmi I, Soriano F. Antimicrobial susceptibility of Corynebacterium group D2. Antimicrob Agents Chemother. 1985 Dec;28(6):845–846. [PMC free article] [PubMed]
  • Soriano F, Fernández-Roblas R, Zapardiel J, Rodríguez-Tudela JL, Avilés P, Romero M. Increasing incidence of Corynebacterium group D2 strains resistant to norfloxacin and ciprofloxacin. Eur J Clin Microbiol Infect Dis. 1989 Dec;8(12):1117–1118. [PubMed]
  • Soriano F, Ponte C, Santamaría M, Castilla C, Fernández Roblas R. In vitro and in vivo study of stone formation by Corynebacterium group D2 (Corynebacterium urealyticum). J Clin Microbiol. 1986 Apr;23(4):691–694. [PMC free article] [PubMed]
  • Soriano F, Ponte C, Santamaría M, Torres A, Fernández-Roblas R. Susceptibility of urinary isolates of Corynebacterium group D2 to fifteen antimicrobials and acetohydroxamic acid. J Antimicrob Chemother. 1987 Sep;20(3):349–355. [PubMed]
  • Verschraegen G, Claeys G, Van den Abeele AM. Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240). Eur J Clin Microbiol Infect Dis. 1988 Feb;7(1):63–66. [PubMed]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...